News Archive

Please consider signing your institution or organization on to a letter to the Office of the National Coordinator for Health Information Technology in support of including sexual orientation and gender identity (SOGI) functionality as a certification requirement for Electronic Health Records under the meaningful use program in 2017. Such a move could dramatically increase SOGI data collection in health care settings, and allow us to better understand and address LGBT health disparities.

Released: April 3, 2014

Statement from the IDSA Center for Global Health Policy and the HIV Medicine Association Confirmation of Deborah L. Birx, MD as Ambassador-at-large and U.S. Global AIDS Coordinator

The confirmation of Dr. Deborah Birx as Ambassador at Large and Global AIDS Coordinator takes the next phase of the fight against the HIV pandemic forward with strength, purpose and great promise. The board and members of HIVMA and the Center for Global Health Policy congratulate Dr. Birx, and affirm our confidence in her passion, knowledge, and demonstrated commitment to confronting, preventing and treating HIV worldwide.

ViiV Healthcare Announces Next Round of the Positive Action Southern Initiative to Support Linkages to HIV/AIDS Care and Treatment Adherence 
Commitment to Hard-Hit Southern U.S. Continues – Letters of Interest Now Open for Organizations in Alabama, Georgia, Louisiana and Mississippi

A new website provides the most up-to-date guidance on appropriate care for practitioners who treat patients infected with hepatitis C virus (HCV).HCVguidelines.org, developed by IDSA and the American Association for the Study of Liver Disease (AASLD) in collaboration with the International Antiviral Society-USA (IAS-USA), offers evidence-based, consensus recommendations for the screening, treatment and management of patients with HCV.

The Foundation for AIDS Research (amfAR) and Treatment Action Group (TAG) called for a deliberate and expedited research agenda designed to begin to end the AIDS epidemic in the United States. The new report, Filling the Gaps in the U.S. Treatment Cascade: Developing a Community-Driven Research Agenda, summarizes key implementation science research priorities developed at a June 2013 gathering of HIV community activists, researchers and policy makers, and health care providers. Participants identified critical areas for research and policy to address gaps in the United States continuum of HIV care, also known as the HIV treatment cascade.

The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has given an opinion on the use of daclatasvir in combination with sofosbuvir in the treatment of chronic (long-term) hepatitis C virus (HCV) infection, in a compassionate-use programme. Click here to read the full press release.

The European Medicines Agency's Committee for Medicinal Products for Human Use adopted a positive opinion, recommending the granting of a marketing authorisation for the medicinal product Sovaldi (sofosbuvir) intended for the treatment of chronic hepatitis C. Click here to read the full press release. 

The U.S. Food and Drug Administration approved Olysio (simeprevir), a new therapy to treat chronic hepatitis C virus infection. Olysio is a protease inhibitor that blocks a specific protein needed by the hepatitis C virus to replicate. It is to be used as a component of a combination antiviral treatment regimen. Click here to read the full press release.